Skip to main content
YIFAN PHARMACEUTICAL CO.,LTD logo

YIFAN PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 002019 ISIN · CNE000001K65 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,497 across all filing types
Latest filing 2025-08-14 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 002019

About YIFAN PHARMACEUTICAL CO.,LTD

https://www.yifanyy.com

Yifan Pharmaceutical Co., Ltd. focuses on the research, development, manufacturing, and commercialization of innovative biologics, specialty small molecules, and traditional Chinese medicine. The company maintains a diverse product portfolio, notably featuring Ryzneuta (efbemalenograstim alfa), a long-acting recombinant human granulocyte colony-stimulating factor used to treat chemotherapy-induced neutropenia. It is also recognized as a major global supplier of Vitamin B5 (D-calcium pantothenate). Operating with a global perspective, the firm manages integrated R&D and production platforms that adhere to international quality standards. Its core activities span drug discovery, clinical development, and large-scale manufacturing, with a strategic emphasis on therapeutic areas such as oncology, hematology, and dermatology.

Recent filings

Filing Released Lang Actions
提名委员会议事规则（2025年8月修订）
Governance Information Classification · 95% confidence The document is titled "提名委员会议事规则" which translates to "Nomination Committee Meeting Rules". It details the rules, composition, responsibilities, meeting procedures, and confidentiality obligations of the Nomination Committee of the company's board. There is no financial data, no mention of financial results, no regulatory filings or announcements, no voting results, no executive changes, no legal proceedings, no capital changes, and no investor presentations. The content is focused on governance structure and internal rules related to the nomination committee, which is a governance-related document. Therefore, the most appropriate classification is Governance Information (CGR). The document length is 4604 characters, which is sufficient for a detailed governance report rather than a brief announcement.
2025-08-14 Chinese
会计师事务所选聘制度（2025年8月修订）
Governance Information Classification · 95% confidence The document is a detailed policy and procedural document regarding the selection and appointment of the company's external audit firm (accounting firm). It outlines the rules, qualifications, procedures, supervision, and penalties related to the appointment and replacement of the auditor. It references relevant laws and regulations, the role of the audit committee, board, and shareholders in the process, and includes detailed governance and compliance requirements. There are no financial statements, audit opinions, or actual audit reports included. The document is not an audit report itself but rather a governance and procedural framework for auditor selection and oversight. Therefore, it fits best under Governance Information (CGR), which covers internal rules, board structure, and governance practices related to audit firm selection and oversight.
2025-08-14 Chinese
投资管理制度(2025年8月修订)
Governance Information Classification · 95% confidence The document is titled '投资管理制度' (Investment Management System) and details the company's internal policies and procedures regarding investment decision-making, approval authorities, voting procedures, and disposal of investments. It references relevant laws and company bylaws, and outlines governance and operational rules for managing investments. There is no indication that this is a financial report, earnings release, or regulatory filing. It is a governance-related document describing internal rules and structures for investment management. Therefore, it fits best under Governance Information (CGR). The document length is 3706 characters, which is relatively short but contains substantive policy content, not just an announcement or certification.
2025-08-14 Chinese
亿帆医药股份有限公司《公司章程》（2025年8月修订）
Governance Information Classification · 100% confidence The document is titled "公司章程" which translates to "Articles of Association" or "Company Bylaws." It contains detailed provisions about the company's organization, shareholder rights, board of directors, management, share issuance, share transfer, shareholder meetings, and other governance-related matters. The content is legal and regulatory in nature, focusing on the internal rules and governance structure of the company rather than financial performance, audit results, or announcements. There is no indication that this is an annual report, audit report, earnings release, or any other financial or market disclosure. It is a governance document outlining the company's internal rules and procedures. Therefore, the appropriate classification is Governance Information (CGR). The document length is substantial (15,000 characters), indicating it is the full text of the governance document, not just an announcement or summary.
2025-08-14 Chinese
董事、高级管理人员离职管理制度
Board/Management Information Classification · 95% confidence The document is titled '董事、高级管理人员离职管理制度' which translates to 'Management System for Departure of Directors and Senior Management'. It details policies and procedures related to the resignation, responsibilities, shareholding restrictions, and accountability mechanisms for directors and senior management personnel leaving the company. There is no indication of financial data, audit results, voting outcomes, or report announcements. The content is focused on internal governance rules regarding management personnel departures. This fits best under 'Board/Management Information (MANG)' which covers announcements or documents about changes or management policies related to the company's board or senior management.
2025-08-14 Chinese
关于董事会换届选举的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the election and qualification of new board members for the company 亿帆医药股份有限公司. It details the nomination and qualifications of non-independent and independent directors, the process for shareholder approval, and includes biographical information of the candidates. There is no financial data, earnings information, or audit content. The document is clearly about changes in the company's board of directors, which fits the category of Board/Management Information (MANG). The document length is 4190 characters, which is consistent with a detailed announcement rather than a full report. Therefore, the appropriate classification is MANG with high confidence.
2025-08-14 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.